New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 2, 2013
15:04 EDTUNH, QCORUnitedHealth alerts physicians to change in authorization process for Acthar
In a network bulletin intended for health care professionals and facilities, dated January 2013, UnitedHealthcare stated that, effective April 1, 2013, the insurer will implement an "important change in the advanced notification review process for the administration of certain specialty medications covered under the medical benefit," including Questcor's (QCOR) H.P. Acthar gel. Currently it is optional for network physicians prescribing H.P. Acthar to submit for advanced notification prior to the administration of these medications, UnitedHealthcare stated. However, as of April 1, all participating network physicians will be required to submit for prior authorization review and approval prior to administration of Acthar for members with UnitedHealthcare commercial coverage plans, including those members currently on therapy. These requests may be subject to medical necessity review to determine coverage, UnitedHealthcare added. In late day trading, shares of Questcor, which had been higher for much of the session, declined 42c, or 1.57%, to $26.30. Reference Link
News For QCOR;UNH From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 14, 2015
07:33 EDTUNHUnitedHealth would consider Optum spinoff if benefits erode, says UBS
Subscribe for More Information
May 11, 2015
07:40 EDTUNHFocus on Vertex will shift to pricing after Orkambi FDA meeting, WSJ says
An FDA advisory committee that meets Tuesday to decide whether to recommend approval of Vertexís Orkambi will be closely watched by health insurers and pharmacy-benefit managers concerned that the experimental cystic-fibrosis drug will be high-priced, said The Wall Street Journal. Vertex hasnít announced a price, but analyst at JPMorgan predict the drug will have a wholesale price of about $287,000 annually per patient. Publicly traded PBM owners include Catamaran (CTRX), which is being acquired by UnitedHealth (UNH), CVS Health (CVS) and Express Scripts (ESRX). Reference Link
07:13 EDTUNHUnitedHealth management to meet with UBS
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use